Chronic smell and flavor loss treatment market to reach $3.83 billion by 2030
The chronic smell and flavor loss treatment market is projected to grow from $2.64 billion in 2025 to $3.83 billion by 2030, driven by more neurological disorders, better diagnosis and new therapies. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.
Why it matters: - Chronic smell and flavor loss treatment is gaining importance as more patients seek care for long-term loss or distortion of smell and taste. - The market is expanding as medical systems recognize sensory loss as both a quality-of-life issue and a possible sign of neurological disease. - The report points to growing demand for treatments that can restore sensory function and improve daily living for people with anosmia, hyposmia, ageusia or dysgeusia.
What happened: - The Business Research Company published its Chronic Smell and Flavor Loss Treatment Global Market Report 2026, covering market size, trends and forecasts through 2035. - The market is projected to rise from $2.64 billion in 2025 to $2.85 billion in 2026. - The report forecasts the market will reach $3.83 billion by 2030. - The report says North America held the largest share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The company offered a free sample of the report and a full version online: the market sample and the full market report.
The details: - The market’s 2025-to-2026 growth implies a 7.9% compound annual growth rate. - The report attributes historical growth to more post-viral smell and taste disorder cases, higher awareness of sensory health conditions, more specialized ENT clinics, better diagnosis of chronic olfactory dysfunction and wider access to pharmacological therapies. - The forecast period implies a 7.6% compound annual growth rate through 2030. - The report highlights neural regeneration therapies, personalized medicine, home-based treatment programs, quality-of-life-focused therapies and more clinical trials as growth drivers ahead. - Emerging trends include regenerative and stem cell-based therapies, structured olfactory training, customized sensory restoration treatments, multimodal therapy options and longer-term sensory rehabilitation. - The report defines chronic smell and flavor loss treatment as medical and therapeutic interventions aimed at restoring smell and taste, reducing symptoms and improving quality of life. - The condition set includes anosmia, hyposmia, ageusia and dysgeusia. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspots infographics, key technology analysis and updated charts.
Between the lines: - Rising neurological disease prevalence is emerging as a major demand driver because smell and taste loss can appear early in neurodegenerative conditions. - The Alzheimer’s Association reported in March 2023 that about 6.7 million Americans age 65 and older were living with Alzheimer’s dementia, with that number projected to reach 13.8 million by 2060. - The market’s growth narrative suggests treatment demand is shifting from symptom management toward longer-term sensory rehabilitation and more individualized care. - North America’s lead and Asia-Pacific’s growth outlook suggest the market is still concentrated in mature health systems while expanding into faster-growing regions.
What’s next: - The market is expected to keep expanding as neural regeneration therapies and personalized medicine move further into clinical use. - More clinical trials focused on sensory disorders could shape the next wave of treatment options. - Home-based programs and structured olfactory training may become more common as part of routine care. - Companies and providers are likely to focus on multimodal therapies and long-term recovery strategies as competition builds.
The bottom line: - Chronic smell and flavor loss treatment is moving from a niche care area to a growing global market, with neurological disease burden and new therapy models driving the next phase of expansion.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Science & Technology Watch
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.